These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 1828550)

  • 21. Tibolone, transdermal estradiol or oral estrogen-progestin therapies: effects on circulating allopregnanolone, cortisol and dehydroepiandrosterone levels.
    Pluchino N; Genazzani AD; Bernardi F; Casarosa E; Pieri M; Palumbo M; Picciarelli G; Gabbanini M; Luisi M; Genazzani AR
    Gynecol Endocrinol; 2005 Mar; 20(3):144-9. PubMed ID: 16019353
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Addition of testosterone to estrogen replacement therapy in oophorectomized women: effects on sexuality and well-being.
    Flöter A; Nathorst-Böös J; Carlström K; von Schoultz B
    Climacteric; 2002 Dec; 5(4):357-65. PubMed ID: 12626215
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of estradiol with micronized progesterone or medroxyprogesterone acetate on risk markers for breast cancer in postmenopausal monkeys.
    Wood CE; Register TC; Lees CJ; Chen H; Kimrey S; Cline JM
    Breast Cancer Res Treat; 2007 Jan; 101(2):125-34. PubMed ID: 16841178
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New evidence regarding hormone replacement therapies is urgently required transdermal postmenopausal hormone therapy differs from oral hormone therapy in risks and benefits.
    Modena MG; Sismondi P; Mueck AO; Kuttenn F; Lignières Bd; Verhaeghe J; Foidart JM; Caufriez A; Genazzani AR;
    Maturitas; 2005 Sep; 52(1):1-10. PubMed ID: 15963666
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of transdermal and oral sequential gestagen in combination with transdermal estradiol: effects on bleeding patterns and endometrial histology.
    Ross AH; Boyd ME; Colgan TJ; Ferenczy A; Fugere P; Lorrain J
    Obstet Gynecol; 1993 Nov; 82(5):773-9. PubMed ID: 8414325
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of four different regimens of hormone replacement therapy on hemostatic parameters: a prospective randomized study.
    Taner MZ; Ozpolat E; Taskiran C; Onan MA; Gursel T; Karabulut E; Gursoy R; Himmetoglu O
    Maturitas; 2006 Feb; 53(3):267-73. PubMed ID: 15978753
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differing effects of low-dose estrogen-progestin therapy and pravastatin in postmenopausal hypercholesterolemic women.
    Davis SR; Goldstat R; Newman A; Berry K; Burger HG; Meredith I; Koch K
    Climacteric; 2002 Dec; 5(4):341-50. PubMed ID: 12626213
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transdermal progesterone cream as an alternative progestin in hormone therapy.
    Leonetti HB; Landes J; Steinberg D; Anasti JN
    Altern Ther Health Med; 2005; 11(6):36-8. PubMed ID: 16320858
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Successful treatment of severe premenstrual syndrome by combined use of gonadotropin-releasing hormone agonist and estrogen/progestin.
    Mortola JF; Girton L; Fischer U
    J Clin Endocrinol Metab; 1991 Feb; 72(2):252A-252F. PubMed ID: 1846868
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increase of estrogen dose deteriorates mood during progestin phase in sequential hormonal therapy.
    Björn I; Sundström-Poromaa I; Bixo M; Nyberg S; Bäckström G; Bäckström T
    J Clin Endocrinol Metab; 2003 May; 88(5):2026-30. PubMed ID: 12727949
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An objective and subjective assessment of uterine blood loss in postmenopausal women on hormone replacement therapy.
    Sporrong T; Rybo G; Mattsson LA; Vilbergson G; Crona N
    Br J Obstet Gynaecol; 1992 May; 99(5):399-401. PubMed ID: 1535788
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transdermal estradiol with oral progestin: biological and clinical effects in younger and older postmenopausal women.
    Bellantoni MF; Harman SM; Cullins VE; Engelhardt SM; Blackman MR
    J Gerontol; 1991 Nov; 46(6):M216-22. PubMed ID: 1834727
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A four week randomised control trial of adjunctive medroxyprogesterone and tamoxifen in women with mania.
    Kulkarni J; Berk M; Wang W; Mu L; Scarr E; Van Rheenen TE; Worsley R; Gurvich C; Gavrilidis E; de Castella A; Fitzgerald P; Davis SR
    Psychoneuroendocrinology; 2014 May; 43():52-61. PubMed ID: 24703170
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Premenstrual tension: a placebo-controlled efficacy study with spironolactone and medroxyprogesterone acetate.
    Hellberg D; Claesson B; Nilsson S
    Int J Gynaecol Obstet; 1991 Mar; 34(3):243-8. PubMed ID: 1673942
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Progesterone effects during sequential hormone replacement therapy.
    Andréen L; Bixo M; Nyberg S; Sundström-Poromaa I; Bäckström T
    Eur J Endocrinol; 2003 May; 148(5):571-7. PubMed ID: 12720542
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A phase III trial of oral high-dose medroxyprogesterone acetate (MPA) versus mepitiostane in advanced postmenopausal breast cancer.
    Izuo M; Yoshida M; Tominaga T; Abe O; Enomoto K; Nomura Y; Kubo K; Takatani O
    Cancer; 1985 Dec; 56(11):2576-9. PubMed ID: 2932213
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A direct comparison of women's perceptions and acceptability of micronised progesterone and medroxyprogesterone acetate in combination with transdermal oestradiol in the management of young postmenopausal women, under 45 years of age.
    Mittal M; Panay N; Supramaniam PR; Savvas M; Cardozo L; Hamoda H
    Post Reprod Health; 2020 Dec; 26(4):210-219. PubMed ID: 33045913
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of ovulation with oral progestins--effectiveness in premenstrual syndrome.
    West CP
    Eur J Obstet Gynecol Reprod Biol; 1990; 34(1-2):119-28. PubMed ID: 2303145
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The use of medroxyprogesterone acetate for relief of climacteric symptoms.
    Morrison JC; Martin DC; Blair RA; Anderson GD; Kincheloe BW; Bates GW; Hendrix JW; Rivlin ME; Forman EK; Propst MG; Needham R
    Am J Obstet Gynecol; 1980 Sep; 138(1):99-104. PubMed ID: 7416212
    [TBL] [Abstract][Full Text] [Related]  

  • 40. When should surgical treatment be considered for premenstrual dysphoric disorder?
    Reid RL
    Menopause Int; 2012 Jun; 18(2):77-81. PubMed ID: 22611227
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.